Botulinum toxin in otorhinolaryngology;Praktische anwendung von botulinumtoxin im kopf-hals-bereich

HNO

Volumn 52, Issue 7, 2004, Pages 635-641

  Rohrbach, S ^a   Laskawi, R ^a  

^a UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

Author keywords

Autonomic nervous system; Botulinum toxin; Dystonia; Facial hyperkinesis; Pain

Indexed keywords

BOTULINUM TOXIN A;

ADVERSE DRUG REACTION; AUTONOMIC DYSFUNCTION; BLEPHAROSPASM; CONFERENCE PAPER; DRUG EFFECT; DRUG EFFICACY; DRUG INDICATION; DRUG USE; DYSTONIA; EAR NOSE THROAT DISEASE; HEMIFACIAL SPASM; HUMAN; HYPERSALIVATION; LACRIMAL GLAND DISEASE; MIGRAINE; MUSCLE DISEASE; NOSE SECRETION; SWEAT GLAND DISEASE; TENSION HEADACHE; TREATMENT INDICATION;

EID: 3142711369     PISSN: 00176192     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00106-004-1098-9     Document Type: Conference Paper

References (20)

1. Brookes GB (2003) Laryngeal dystonia. In: Moore P (ed) Botulinum toxin treatment. Blackwell, Oxford, pp 181-205
2. Ellies M, Laskawi R, Rohrbach-Volland S, Arglebe C, Beuche W (2002) Botulinum toxin to reduce saliva flow: Selected indications for ultrasound-guided toxin application into salivary glands. Laryngoscope 112: 82-86
3. Jost W (2004) Schmerzsyndrome. In: Laskawi R, Roggenkämper P (Hrsg) Botulinumtoxin-Therapie im Kopf-Hals-Bereich. U rban & Vogel, München, S 284-294
4. Kerner J (1817) Vergiftung durch verdorbene Würste. Tübinger Blätter für Naturwissenschaften und Arzneykunde 3: 1-2S
5. Kim K-S, Kim S-S, Yoon J-H, Han JW (1998) The effect of botulinum toxin type A. Injection for intrinsic rhinitis. J Laryngol Otol 112: 248-251
6. Laskawi R, Ellies M, Drobik C, Bätz A (1994) Botulinum toxin treatment in patients with hemifacial spasm. Eur Arch Otorhinolaryngol 251: 271-274
7. Laskawi R (1998). Die therapeutische Anwendung von Botulinum-Toxin im Hals-Nasen-Ohren-Bereich. Teil 1: Die Behandlung von Bewegungsstörungen der mimischen Muskulatur. HNO 46: 281-287
8. Laskawi R, Rohrbach S (2001) Oromandibuläre Dystonien. Laryngorhinootologie 80: 708-713
9. Laskawi R, Rohrbach S (2001) Treatment of gustatory sweating with botulinum toxin: Special aspects. ORL 63: 294-297
10. Laskawi R, Rohrbach S (2002) Frey's syndrome. Treatment with botulinum toxin. In: Kreyden OP, Böni R, Burg G (eds) Hyperhidrosis and botulinum toxin in dermatology. Curr Probl Dermatol 30: 170-177
11. Marchese Ragona R, Blotta P, Pastore A, Tugnoli V, Eleopra R, De Grandis D (1999) Management of parotid sialocele with botulinum toxin. Laryngoscope 109: 1344-1346
12. Mrugalla S, Ellies M, Laskawi R (2004) Faziale Hyperhidrose. In: Laskawi R, Roggenkämper P (Hrsg) Botulinumtoxin-Therapie im Kopf-Hals-Bereich. Urban & Vogel, München, S 308-312
13. Naumann M, Jost WH, Toyka KV (1999) Botulinum toxin in the treatment of neurological disorders of the autonomic nervous system. Arch Neurol 56: 914-916
14. Pototsching C, Thumfart F (2004) Spasmodische Dysphonie und andere Anwendungen. In: Laskawi R, Roggenkämper P (Hrsg) Botulinum-Toxin-Therapie im Kopf-Hals-Bereich. Urban & Vogel, München, S 180-181
15. Rohrbach S, Olthoff A, Laskawi R, Giefer B, Götz W (2001) Botulinum toxin type A induces apoptosis in nasal glands of guinea pigs. Ann Otol Laryngol 110: 1045-1050
16. Rohrbach S, Laskawi R (2001) Minimally invasive application of botulinum toxin type A in nasal hypersecretion. ORL 63: 382-384
17. Rohrbach S, Olthoff A, Laskawi R, Götz W (2002) Neuronal nitric oxide synthase-immunoreactivity - A neuromodulating system independent of peripheral nasal gland denervation in guinea pig nasal mucosal tissue after treatment with botulinum toxin type A.ORL 64(5): 330-334
18. Shaari CM, Sanders I, Wu BL, Biller HF (1995) Rhinorrhoea is decreased in dogs after nasal application of botulinum toxin. Otolaryngol Head Neck Surg 112: 566-571
19. Stacy M (2000) Idiopathic cervical dystonia: an overview. Neurology 55: S2-S8
20. Van Ermengem EP (1897) Über einen neuen anaeroben Bacillus und seine Beziehung zum Botulismus. Z Hyg Infektionskrankh 26: 1-56